[The evaluation of the effect of formol in the detection of Cryptosporidium sp. oocysts in feces by the methods of Sheater and of the Coprotest] NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[The evaluation of the effect of formol in the detection of Cryptosporidium sp. oocysts in feces by the methods of Sheater and of the Coprotest]

Rev Hosp Clin Fac Med Sao Paulo. 1992 Sep-Oct;47(5):231-3. Unique Identifier : AIDSLINE MED/94053311
Amato Neto V; Braz LM; Campos R; Ogassawara S; Motta HM; Morandi NF; Marques HH; Laboratorio de Investigacao Medica-Parasitologia, Hospital; das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo.

Abstract: Frequently it is necessary to search for oocysts of Cryptosporidium sp. in the stools potentially contaminated with human immunodeficiency virus (HIV). For the protection of the laboratory personal handling fecal material formalin has been considered useful. However, this disinfectant has not been evaluated when the stool examinations were performed with the technique of flotation-centrifugation in concentrated solution of sugar and with that of Coprotest. Our experience indicates that the use of formalin may interfere with the results when the first of these methods is used, but it does not alter the results of the second one. This information is of importance for the future assistential and scientific studies.
Keywords: Acquired Immunodeficiency Syndrome/PREVENTION & CONTROL/ TRANSMISSION Animal Comparative Study Cryptosporidium/DRUG EFFECTS/*ISOLATION & PURIF Disease Transmission, Patient-to-Professional/PREVENTION & CONTROL Disinfectants/*PHARMACOLOGY English Abstract Evaluation Studies Feces/MICROBIOLOGY/*PARASITOLOGY Formaldehyde/*PHARMACOLOGY Human HIV-1 Laboratory Personnel Methods JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/prevention&control/transmissionanimalcomparativestudycryptosporidium/drugeffects/KWDisolation&purifdiseasetransmission,patient-to-professional/prevention&controldisinfectants/KWDpharmacologyenglishabstractevaluationstudiesfeces/microbiology/KWDparasitologyformaldehyde/KWDpharmacologyhumanhiv-1laboratorypersonnelmethodsjournalarticle
940228
M9420801

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .